HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,011 Cr | ₹933 Cr | ₹662 Cr | ₹828 Cr | ₹703 Cr |
What is the latest Total Current Liabilities ratio of HIKAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,011 Cr |
| Mar2024 | ₹933 Cr |
| Mar2023 | ₹662 Cr |
| Mar2022 | ₹828 Cr |
| Mar2021 | ₹703 Cr |
How is Total Current Liabilities of HIKAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,011 Cr | 8.36 | |
| Mar2024 | ₹933 Cr | 41.00 | |
| Mar2023 | ₹662 Cr | -20.12 | |
| Mar2022 | ₹828 Cr | 17.75 | |
| Mar2021 | ₹703 Cr | - | |
Compare Total Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,835.9 Cr | 6% | 3.5% | -33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 6% |
3.5% |
-33.3% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses